& Trautmann, M
Shortacting GHRH analog for vitality and performance
RDs play a central role in this process, providing MNT that evolves based on the patients clinical response, dietary intake, muscle mass, and tolerance to medication.50,51 Before initiating GLP-1 therapy, clinicians should assess baseline diet, medical conditions, disordered eating patterns, and social determinants of health to identify barriers and tailor care.19 Ongoing monitoring should include changes in weight, muscle strength, and nutrient intake, using flexible care delivery models such as telehealth, group visits, or Food is Medicine programs to improve access and equity to nutrient dense foods.19 MNT Recommendations To support long-term success, lifestyle interventions must be structured and ongoing
In addition, the administration of AcM was correlated with systemic reduction of hypoxanthine, histidine, and uracil, but increased pyruvate, 2-oxoglutarate, and glucose in connection to a decreased caecal -diversity and improved performance in broilers [25]